Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database

Figure 3

Trends in antiglaucoma ophthalmic solutions. PG: prostaglandin analogue; BB: beta blocker; CAI: carbonic anhydrase inhibitor.